Logo image of KIDS

ORTHOPEDIATRICS CORP (KIDS) Stock Fundamental Analysis

NASDAQ:KIDS - Nasdaq - US68752L1008 - Common Stock - Currency: USD

21.89  -0.56 (-2.49%)

After market: 21.89 0 (0%)

Fundamental Rating

3

KIDS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. KIDS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, KIDS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

KIDS had negative earnings in the past year.
KIDS had a negative operating cash flow in the past year.
In the past 5 years KIDS reported 4 times negative net income.
KIDS had a negative operating cash flow in each of the past 5 years.
KIDS Yearly Net Income VS EBIT VS OCF VS FCFKIDS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M

1.2 Ratios

KIDS has a better Return On Assets (-8.65%) than 63.64% of its industry peers.
KIDS has a better Return On Equity (-11.72%) than 66.31% of its industry peers.
Industry RankSector Rank
ROA -8.65%
ROE -11.72%
ROIC N/A
ROA(3y)-4.16%
ROA(5y)-5.62%
ROE(3y)-5.3%
ROE(5y)-7.43%
ROIC(3y)N/A
ROIC(5y)N/A
KIDS Yearly ROA, ROE, ROICKIDS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

The Gross Margin of KIDS (72.81%) is better than 83.96% of its industry peers.
In the last couple of years the Gross Margin of KIDS has remained more or less at the same level.
KIDS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 72.81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.71%
KIDS Yearly Profit, Operating, Gross MarginsKIDS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

5

2. Health

2.1 Basic Checks

KIDS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for KIDS has been increased compared to 1 year ago.
KIDS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for KIDS is higher compared to a year ago.
KIDS Yearly Shares OutstandingKIDS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
KIDS Yearly Total Debt VS Total AssetsKIDS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

KIDS has an Altman-Z score of 2.64. This is not the best score and indicates that KIDS is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.64, KIDS is doing good in the industry, outperforming 65.24% of the companies in the same industry.
A Debt/Equity ratio of 0.21 indicates that KIDS is not too dependend on debt financing.
KIDS's Debt to Equity ratio of 0.21 is in line compared to the rest of the industry. KIDS outperforms 54.01% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 2.64
ROIC/WACCN/A
WACC8.8%
KIDS Yearly LT Debt VS Equity VS FCFKIDS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 6.19 indicates that KIDS has no problem at all paying its short term obligations.
KIDS's Current ratio of 6.19 is amongst the best of the industry. KIDS outperforms 82.89% of its industry peers.
KIDS has a Quick Ratio of 2.99. This indicates that KIDS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.99, KIDS is in the better half of the industry, outperforming 64.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.19
Quick Ratio 2.99
KIDS Yearly Current Assets VS Current LiabilitesKIDS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for KIDS have decreased strongly by -81.91% in the last year.
The Revenue has grown by 31.28% in the past year. This is a very strong growth!
Measured over the past years, KIDS shows a very strong growth in Revenue. The Revenue has been growing by 23.04% on average per year.
EPS 1Y (TTM)-81.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-35.29%
Revenue 1Y (TTM)31.28%
Revenue growth 3Y27.84%
Revenue growth 5Y23.04%
Sales Q2Q%17.29%

3.2 Future

KIDS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.69% yearly.
KIDS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.32% yearly.
EPS Next Y18.2%
EPS Next 2Y15.89%
EPS Next 3Y14.69%
EPS Next 5YN/A
Revenue Next Year17.84%
Revenue Next 2Y17.49%
Revenue Next 3Y17.32%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
KIDS Yearly Revenue VS EstimatesKIDS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
KIDS Yearly EPS VS EstimatesKIDS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KIDS. In the last year negative earnings were reported.
Also next year KIDS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KIDS Price Earnings VS Forward Price EarningsKIDS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KIDS Per share dataKIDS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

A more expensive valuation may be justified as KIDS's earnings are expected to grow with 14.69% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.89%
EPS Next 3Y14.69%

More info and screens

0

5. Dividend

5.1 Amount

KIDS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORTHOPEDIATRICS CORP

NASDAQ:KIDS (7/11/2025, 8:00:02 PM)

After market: 21.89 0 (0%)

21.89

-0.56 (-2.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners71.13%
Inst Owner Change0%
Ins Owners5.23%
Ins Owner Change4.01%
Market Cap542.22M
Analysts83.08
Price Target36.21 (65.42%)
Short Float %6.6%
Short Ratio8.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-57.99%
Min EPS beat(2)-115.9%
Max EPS beat(2)-0.09%
EPS beat(4)1
Avg EPS beat(4)-36.84%
Min EPS beat(4)-115.9%
Max EPS beat(4)6.92%
EPS beat(8)4
Avg EPS beat(8)-9.76%
EPS beat(12)7
Avg EPS beat(12)5.24%
EPS beat(16)10
Avg EPS beat(16)15.36%
Revenue beat(2)1
Avg Revenue beat(2)0.3%
Min Revenue beat(2)-0.58%
Max Revenue beat(2)1.19%
Revenue beat(4)1
Avg Revenue beat(4)-0.3%
Min Revenue beat(4)-1.39%
Max Revenue beat(4)1.19%
Revenue beat(8)2
Avg Revenue beat(8)-0.3%
Revenue beat(12)3
Avg Revenue beat(12)-0.81%
Revenue beat(16)5
Avg Revenue beat(16)-0.56%
PT rev (1m)0%
PT rev (3m)-6.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.26%
EPS NY rev (1m)-3.51%
EPS NY rev (3m)-3.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.2%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.55
P/FCF N/A
P/OCF N/A
P/B 1.56
P/tB 3.11
EV/EBITDA N/A
EPS(TTM)-1.75
EYN/A
EPS(NY)-1.07
Fwd EYN/A
FCF(TTM)-1.5
FCFYN/A
OCF(TTM)-0.99
OCFYN/A
SpS8.58
BVpS14.01
TBVpS7.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.65%
ROE -11.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 72.81%
FCFM N/A
ROA(3y)-4.16%
ROA(5y)-5.62%
ROE(3y)-5.3%
ROE(5y)-7.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.71%
F-Score3
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 66.37%
Cap/Sales 5.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.19
Quick Ratio 2.99
Altman-Z 2.64
F-Score3
WACC8.8%
ROIC/WACCN/A
Cap/Depr(3y)87.97%
Cap/Depr(5y)110.98%
Cap/Sales(3y)9.42%
Cap/Sales(5y)12.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-81.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-35.29%
EPS Next Y18.2%
EPS Next 2Y15.89%
EPS Next 3Y14.69%
EPS Next 5YN/A
Revenue 1Y (TTM)31.28%
Revenue growth 3Y27.84%
Revenue growth 5Y23.04%
Sales Q2Q%17.29%
Revenue Next Year17.84%
Revenue Next 2Y17.49%
Revenue Next 3Y17.32%
Revenue Next 5YN/A
EBIT growth 1Y-14.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year156.75%
EBIT Next 3Y50.36%
EBIT Next 5YN/A
FCF growth 1Y-6.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2.01%
OCF growth 3YN/A
OCF growth 5YN/A